Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

[Impact of P16ink4a and P15ink4b on Human Hepatocellular Carcinoma Cell Proliferation and Apoptosis].

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Effects of P16 Gene on Biological Behavious in Hepatocellular Carcimoma Cells

[The Effects of P16 and Rb Protein Expression and NF-kappaB Activity on Hepatocarcinogenesis].

The Effect of Anti-Oncogene P15, P16 on the Proliferation of a Human Cholangio Carcinoma Cell Line

Proliferative and Invasive Effects of Inhibitors of Kinase 4 (p15ink4b and P16ink4a/CDKN2) Gene Activation on RKO Human Colorectal Cancer Cells

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Effect of Exogenous P16ink4a and Hrbl Genes on Cell Cycle Regulation of Osteosarcoma Cell Line

Cellular and Molecular Evidence for Malignancy-Inhibitory Functions of P15rs.

Polymorphism of P16ink4a Gene and Rare Mutation of P15ink4b Gene Exon2 in Primary Hepatocarcinoma

Effect of P16 Gene on Carcinogenesis of Hepatitis B Virus Related Hepatocellular Carcinoma

P16 Reactivation Induces Anoikis and Exhibits Antitumour Potency by Downregulating Akt/survivin Signalling in Hepatocellular Carcinoma Cells.

[P16 and Cyclind1 Protein Expression and P16 Gene Mutation in Primary Human Hepatocellular Carcinoma].

[A Study on the Inactivation of P16 Genes and the Expression of P16 Protein in Primary Hepatocellular Carcinomas].

Retrovirus-mediated P16ink4a Gene Therapy for Human Hepatocellular Carcinoma

Synergistic Effect of the Expression of P16ink4 Gene and Retinoblastoma Gene in Lung Cancer

The Study of the Inhibitory Effect of Anti-Oncogene P16 on the Proliferation of Human Cholangiocarcinoma Cell Line

[Effect of Tyrosine-Kinase Inhibitor on P15 Gene Transfected K562 Cells].

Cell Proliferation, Apoptosis and the Related Regulators P27, P53 Expression in Hepatocellular Carcinoma

p53 Deficiency leads to compensatory up-regulation of p16INK4a.

A PILOT STUDY ON EFFECT OF P15 ON PROLIFERATION OF CHOLANGIOCARCINOMA